The major global manufacturers of Age-Related Macular Degeneration (AMD) Treatment Drugs Market include: Ionis Pharmaceuticals, Inc, Bausch Health Companies Inc, Regeneron Pharmaceuticals Inc, Biogen, Novartis AG, Sanofi S.A., Bayer AG, Coherus Biosciences Inc, F. Hoffmann-La Roche Ltd, Apellis Pharmaceuticals Inc, AbbVie, Pfizer Inc., Amgen Inc., Samsung Bioepis.

The Global “Age-Related Macular Degeneration (AMD) Treatment Drugs Market” Research Report 2024 offers a comprehensive analysis of the market, including its size, share, trends, growth opportunities, and potential for expansion. The report segments the market by value and volume, focusing on manufacturing, application, type, and geography. It provides a geographic analysis covering regions such as North America, Europe, Asia-Pacific, and the Rest of the World. Additionally, the Age-Related Macular Degeneration (AMD) Treatment Drugs market within each region is further segmented by major countries, including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Age-Related Macular Degeneration (AMD) Treatment Drugs Market Analysis and Insights:

Age-related macular degeneration (AMD) is a progressive eye disease that affects the macula, a part of the retina responsible for central vision. The cells in the macula become damaged and begin to die, causing vision loss as a person ages. The disease is typically categorized into two types: dry age-related macular degeneration (AMD) and wet age-related macular degeneration (AMD). Dry AMD is more common and involves the formation of small, yellow deposits in the macula, while wet AMD is less common and involves the growth of abnormal blood vessels beneath the macula. In dry AMD, treatment options include vitamin supplements and lifestyle changes to reduce risk factors. In wet AMD, treatment involves medications that are injected into the eye to stop the growth of abnormal blood vessels. This treatment is called abnormal endothelial growth factor (anti-VEGF) therapy, and it works by blocking the protein that stimulates the growth of abnormal blood vessels.

The global Age-Related Macular Degeneration (AMD) Treatment Drugs market was valued at USD 10110 million in 2023 and is anticipated to reach USD 14950 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Age-Related Macular Degeneration (AMD) Treatment Drugs manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers.

Some of the players in the research report include:

  • Ionis Pharmaceuticals, Inc
  • Bausch Health Companies Inc
  • Regeneron Pharmaceuticals Inc
  • Biogen
  • Novartis AG
  • Sanofi S.A.
  • Bayer AG
  • Coherus Biosciences Inc
  • F. Hoffmann-La Roche Ltd
  • Apellis Pharmaceuticals Inc
  • AbbVie
  • Pfizer Inc.
  • Amgen Inc.
  • Samsung Bioepis

Inquire or Share Your Questions If Any Before the Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/27877080

Age-Related Macular Degeneration (AMD) Treatment Drugs segment by Type:

  • Aflibercept
  • Ranibizumab
  • Others

Age-Related Macular Degeneration (AMD) Treatment Drugs segment by Application:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2031.

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France

To Understand How Covid-19 Impact Is Covered in This Report – https://absolutereports.com/enquiry/request-covid19/27877080

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Age-Related Macular Degeneration (AMD) Treatment Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Age-Related Macular Degeneration (AMD) Treatment Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Age-Related Macular Degeneration (AMD) Treatment Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Age-Related Macular Degeneration (AMD) Treatment Drugs industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Age-Related Macular Degeneration (AMD) Treatment Drugs.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapters included in this report:

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Age-Related Macular Degeneration (AMD) Treatment Drugs manufacturers competitive landscape, price, output and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Age-Related Macular Degeneration (AMD) Treatment Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Age-Related Macular Degeneration (AMD) Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 5: Provides the analysis of various market segments according to product type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, revenue, , price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Analysis of sales channel, distributors and customers
  • Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

More.

Purchase this Report (Price 2900 USD for a Single-User License) – https://absolutereports.com/purchase/27877080

Detailed TOC of Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Research Report

1 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Overview

1.1 Product Definition

1.2 Age-Related Macular Degeneration (AMD) Treatment Drugs by Type

1.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Value Comparison by Type (2024-2030)

1.3 Age-Related Macular Degeneration (AMD) Treatment Drugs by Application

1.3.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Value by Application (2024-2030)

1.4 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size Estimates and Forecasts

1.4.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue 2019-2030

1.4.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales 2019-2030

1.4.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Competition by Manufacturers

2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Age-Related Macular Degeneration (AMD) Treatment Drugs, Industry Ranking, 2024 VS 2023 VS 2024

2.5 Global Key Manufacturers of Age-Related Macular Degeneration (AMD) Treatment Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Age-Related Macular Degeneration (AMD) Treatment Drugs, Product Type & Application

2.7 Global Key Manufacturers of Age-Related Macular Degeneration (AMD) Treatment Drugs, Date of Enter into This Industry

2.8 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Competitive Situation and Trends

2.8.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Age-Related Macular Degeneration (AMD) Treatment Drugs Players Market Share by Revenue

2.8.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Scenario by Region

3.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region: 2019-2030

3.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region: 2019-2024

3.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region: 2025-2030

3.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Region: 2019-2030

3.3.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Region: 2019-2024

3.3.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Region: 2025-2030

3.4 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Facts & Figures by Country

3.4.1 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2019-2030)

3.4.3 North America Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Facts & Figures by Country

3.5.1 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2019-2030)

3.5.3 Europe Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Region (2019-2030)

3.6.3 Asia Pacific Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Facts & Figures by Country

3.7.1 Latin America Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2019-2030)

3.7.3 Latin America Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Type (2019-2030)

4.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Type (2019-2024)

4.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Type (2025-2030)

4.1.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Type (2019-2030)

4.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Type (2019-2030)

4.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Type (2019-2024)

4.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Type (2025-2030)

4.2.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Application (2019-2030)

5.1.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Application (2019-2024)

5.1.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales by Application (2025-2030)

5.1.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Market Share by Application (2019-2030)

5.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Application (2019-2030)

5.2.1 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Application (2019-2024)

5.2.2 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue by Application (2025-2030)

5.2.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Age-Related Macular Degeneration (AMD) Treatment Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Manufacture 1

6.1.1 Manufacture 1 Company Information

6.1.2 Manufacture 1 Description and Business Overview

6.1.3 Manufacture 1 Age-Related Macular Degeneration (AMD) Treatment Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Manufacture 1 Age-Related Macular Degeneration (AMD) Treatment Drugs Product Portfolio

6.1.5 Manufacture 1 Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Industry Chain Analysis

7.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Age-Related Macular Degeneration (AMD) Treatment Drugs Production Mode & Process

7.4 Age-Related Macular Degeneration (AMD) Treatment Drugs Sales and Marketing

7.4.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Sales Channels

7.4.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Distributors

7.5 Age-Related Macular Degeneration (AMD) Treatment Drugs Customers

8 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Dynamics

8.1 Age-Related Macular Degeneration (AMD) Treatment Drugs Industry Trends

8.2 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Drivers

8.3 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Challenges

8.4 Age-Related Macular Degeneration (AMD) Treatment Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

Contact Us:

Absolute Reports

Phone: US +1 (888) 690-5999

UK +44 8083 023308

Web: https://www.absolutereports.com

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]